钙通道阻滞剂对于系统高血压的治疗提供了一种新的途径,他们在治疗轻度、中度、重度高血压中,临床研究提示了一个重要的作用,对有相应疾病的病人以及传统用利尿药物治疗的病人来说,钙阻滞剂治疗表现一种有吸引力的选择。因此,尽管有效的钙通道阻滞剂具有许多共同作用,但在化学结构上他们是有区别的,并有不同的药物特性和附属特性。此外,钙通道阻带剂的高成本与利尿药和其他抗高血压药物比较,可能限制有效病人的使用而显示出副作用和耐受性。 Calcium channel blockers provide a new avenue for the treatment of systemic hypertension. They have shown an important role in the treatment of mild, moderate, and severe hypertension. Patients with corresponding diseases, as well as traditional Calcium blockers show an attractive option for patients treated with diuretics. Thus, while effective calcium channel blockers have many synergistic functions, they are chemically distinct and have different pharmaceutical and accessory properties. In addition, the high cost of calcium channel blockers, compared with diuretics and other antihypertensives, may limit the use of effective patients and show side effects and tolerability.